P/E ratio for Zoetis (ZTS)

P/E ratio history for Zoetis from 2013 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Eli Lilly LLY	146	334.78%	🇺🇸 USA
Merck MRK	54.8	62.96%	🇺🇸 USA
Pfizer PFE	14.3	-57.55%	🇺🇸 USA
Phibro Animal Health PAHC	30.5	-9.24%	🇺🇸 USA
Kindred Biosciences KIN	N/A	N/A	🇺🇸 USA
Heska Corporation HSKA	-62.2	-284.80%	🇺🇸 USA
Sanofi SNY	15.2	-54.73%	🇫🇷 France

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.